Targeting mitochondrial damage: shining a new light on immunotherapy.

Wenjuan Zeng1,2, Menghui Wang1,2, Yuxin Zhang3

  • 1Department of Gastrointestinal Surgery, The 2Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

PubMed
Summary

Mitochondrial damage worsens cancer by affecting the immune system and tumor microenvironment. Protecting mitochondria or modulating immune cells like macrophages may improve cancer therapy outcomes.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.5K